Danicopan Completed Phase 2 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

Back to Danicopan
IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04988035ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19